• 1
    Organ Procurement and Transplantation Network-HRSA. Final rule with comment period. Fed Regist 1998; 63: 16296.
  • 2
    Freeman RB, Rohrer RJ, Katz E, et al. Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time. Liver Transpl 2001; 7: 173.
  • 3
    Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
  • 4
    Edwards EB, Harper AM. Application of a continuous disease severity score to the OPTN liver waiting list. Clin Transpl 2001; 15: 19.
  • 5
    Brown RS Jr, Kumar KS, Russo MW, et al. Model for end-stage liver disease and Child–Turcotte–Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002; 8: 278.
  • 6
    Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
  • 7
    Wiesner R, Edwards E, Freeman R, et al. United Network for Organ Sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
  • 8
    Institute of Medicine. Analysis of waiting times. In: Committee on Organ Transplantation. Assessing current policies and the potential impact of the DHHS final rule. Washington, DC: National Academy Press, 1999: 57–78.
  • 9
    Freeman RB Jr, Edwards EB. Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy. Liver Transpl 2000; 6: 543.
  • 10
    United Network for Organ Sharing. Available at: Accessed May, 2002.
  • 11
    Kremers WK, van IJperen M, Kim WR, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004; 39: 764.
  • 12
    Freeman RB Jr, Wiesner RH, Harper A, et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, and UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851.
  • 13
    Saab S, Wang V, Ibrahim AB, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9: 473.
  • 14
    Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004; 77: 99.
  • 15
    Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258.
  • 16
    Child C, Turcotte J. Surgery and portal hypertension. In: ChildCG, ed. The Liver and Portal Hypertension. Philadelphia: Saunders, 1964: 50.
  • 17
    Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646.
  • 18
    Cox DR Regression models and life-tables. J R Stat Soc 1972; 34: 187.
  • 19
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
  • 20
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163.
  • 21
    Abouassi SG, Mihas AA, Wiliams LM, et al. MELD and CTP score are equivalent predictors of mortality in cirrhotic veterans referred for orthotopic liver transplantation (OLT). Hepatology 2001; 34: 207A.
  • 22
    Freeman RB, Wiesner RH, Edwards E, et al. United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7.
  • 23
    Gheorghe L, Popescu I, Iacob R, Iacob S, Gheorghe C. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time. Transpl Int 2005; 18: 572.
  • 24
    Biggins SW, Rodriguez HJ, Bacchetti P, et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005; 41: 32.
  • 25
    Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23: 164.
  • 26
    Bustamante J, Rimola A, Ventura PJ, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890.
  • 27
    Graham DY, Smith JL The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800.
  • 28
    Altman C, Grange JD, Amiot X, et al. Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation. J Gastroenterol Hepatol 1995; 10: 47.
  • 29
    Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567.
  • 30
    Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004; 40: 802.
  • 31
    Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol. 2000; 32(Suppl. 1): 157.
  • 32
    Onaca NN, Levy MF, Sanchez EQ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003; 9: 117.
  • 33
    Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology 2001; 33: 473.
  • 34
    Fontana I, Santori G, Ginevri F, et al. Impact of pretransplant dialysis on early graft function in pediatric kidney recipients. Transpl Int 2005; 18: 785.